Alphatec Holdings lowered its 2026 revenue guidance from approximately $882 million to $862 million following its third-quarter results, citing lower biologics attachment rates, softer procedure volumes, and supply constraints. This $20 million reduction caused a sharp decline in ATEC shares. Legal firm Levi & Korsinsky is investigating potential securities violations and encourages shareholders who suffered losses to seek a free evaluation for possible recovery. Investors who bought ATEC stock and lost money after the guidance cut may be eligible to participate in the investigation without upfront costs or court appearances.
Alphatec Holdings' recent revenue guidance cut and investigation notice provide context for market watchers. For readers following the health sector, here is Pluang's market snapshot as of Oct 31, 2026 03:11 WIB: Among 150 priced US health stocks, 51 rose and 99 fell today. Notable movers include Inovio Pharmaceuticals Inc (INO) at USD 0.62 with a 19.66% drop, Illumina, Inc. (ILMN) at USD 236.36 down 18.51%, and American Well Corp (AMWL) at USD 12.71 down 15.15%.
Philips has introduced the HyperVue Integrated System in the U.S., a fixed, single-room setup combining DeepOCT+NIRS imaging with X1-FFR physiology assessment for coronary interventions. This system is designed to streamline cath lab workflows by kee...
Atlas Copco Group completed Expansion Week in the US, unveiling three major manufacturing expansions in New York and South Carolina. The new facilities will increase production of oil-free compressors, dry vacuum pumps, and gas and process equipment,...
Mohawk Industries reported Q3 2026 net sales of $2.8 billion, up about 1%, driven by price increases offsetting lower volumes amid weak demand. Adjusted EPS rose 2% to $2.72, supported by productivity and pricing strategies. The company generated $39...
The global Drone as First Responder (DFR) market, valued at $3 billion in 2025, is projected to grow to $11 billion by 2033 at a 17.7% CAGR. Growth is fueled by advancements in automated drone-in-a-box systems, beyond visual line of sight (BVLOS) ope...
Canary Capital amended its Staked INJ ETF proposal to list on Nasdaq instead of Cboe BZX, with the ticker INJC. The ETF aims to track the price of Injective (INJ) tokens it holds, with staking as a secondary goal, expecting to stake at least 90% of I...
